Bergendal B, Bergendal T, Hallonsten A-L, Koch G, Kvint S. A multidisciplinary approach to oral rehabilitation with osseointegrated implants in children and adolescents with multiple aplasia. Eur J Orthod 1996; 18: 119-129.

Cohen BA. Incontinentia Pigmenti. Neurocutaneous Dis 1987; 3: 361-376.

Courtois G, Smahi A, Reichenbach J, Döffinger R, Cancrini C, Bonnet M et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003; 112: 983-985.

Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 2008 Oct 11. [Epub ahead of print]

Heinesen-Esholdt I. Incontinentia pigmenti. Nordisk medicin 1994; 109: 58-60.

Holmström G, Thoren K. Ocular manifestations of incontinentia pigmenti.

Acta Ophthalmol Scand 2000; 78: 348-353.

Landy SJ, Donnai D. Incontinentia Pigmenti (Bloch-Sultzberger syndrome). J Med Genet 1993; 30: 53-59.

Mancini AJ, Lawley LP, Uzel G. X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis. Arch Dermatol 2008; 144: 342-346.

The International Incontinentia Pigmenti (IP) Consortium. Genomic rearrangement in NEMO impairs NF-kappabeta activation and is a cause of incontinentia pigmenti. Nature 2000; 405: 466-472.